Guerbet attributes strong performance to agent range
This article was originally published in Clinica
Executive Summary
French contrast agent manufacturer Guerbet reported a 16% increase in revenues during the first six months of 1995 to Fr 546 million ($111 million) compared with last year. The company had net profits of Fr 30.9 million, a rise of almost 30% over the first six months in 1994.